These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 18593543
1. [Implications of the Renin-Angiotensin system in diabetic nephropathy]. Ortega-Pierres LE, Higareda-Mendoza AE, Pardo-Galván MA, Beltrán-Peña E, Gómez-García A, Farías-Rodríguez VM, Alvarez-Aguilar C. Rev Med Inst Mex Seguro Soc; 2007; 45(6):601-10. PubMed ID: 18593543 [Abstract] [Full Text] [Related]
2. [Genetic factors with significance in pathogenesis of diabetic nephropathy--the role of polymorphism of renin-angiotensin system genes]. Grzeszczak W. Przegl Lek; 2000; 57 Suppl 3():19-24. PubMed ID: 11293230 [Abstract] [Full Text] [Related]
3. Gene polymorphism of the renin-angiotensin system and progression of diabetic nephropathy. Orisio S. J Nephrol; 1999; 12(1):9-17. PubMed ID: 10202997 [Abstract] [Full Text] [Related]
4. Angiotensin I-converting enzyme: a pathogenetic role in diabetic renal damage? Lely AT, Luik PT, Navis G. Curr Diabetes Rev; 2007 Feb; 3(1):41-52. PubMed ID: 18220655 [Abstract] [Full Text] [Related]
5. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients. Böger CA, Götz AK, Krüger B, Hösl M, Schmitz G, Riegger GA, Krämer BK. Eur J Med Res; 2005 Apr 20; 10(4):161-8. PubMed ID: 15946912 [Abstract] [Full Text] [Related]
7. Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease. Rudnicki M, Mayer G. Pharmacogenomics; 2009 Mar 20; 10(3):463-76. PubMed ID: 19290794 [Abstract] [Full Text] [Related]
8. Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. Konoshita T, Wakahara S, Mizuno S, Motomura M, Aoyama C, Makino Y, Kawai Y, Kato N, Koni I, Miyamori I, Mabuchi H. Diabetes Care; 2006 Apr 20; 29(4):848-52. PubMed ID: 16567826 [Abstract] [Full Text] [Related]
11. Preventing end stage renal disease in diabetic patients--genetic aspect (part I). Jacobsen PK. J Renin Angiotensin Aldosterone Syst; 2005 Mar 20; 6(1):1-14. PubMed ID: 16088846 [Abstract] [Full Text] [Related]
12. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F. J Clin Invest; 1997 Apr 01; 99(7):1585-95. PubMed ID: 9120002 [Abstract] [Full Text] [Related]
17. [The significance of candidate genes' polymorphism in the development of diabetic nephropathy]. Grzeszczak W, Zukowska-Szczechowska E. Wiad Lek; 1998 Apr 01; 51 Suppl 2():11-23. PubMed ID: 9686528 [Abstract] [Full Text] [Related]
18. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients. El-Baz R, Settin A, Ismaeel A, Khaleel AA, Abbas T, Tolba W, Abd Allah W, Sobh MA. J Renin Angiotensin Aldosterone Syst; 2012 Dec 01; 13(4):472-7. PubMed ID: 22554825 [Abstract] [Full Text] [Related]